Stock ALSEN SENSORION
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sensorion

Equities

ALSEN

FR0012596468

Biotechnology & Medical Research

Market Closed - Euronext Paris
Other stock markets
 10:46:00 2024-04-26 am EDT 		5-day change 1st Jan Change
0.706 EUR -0.56% Intraday chart for Sensorion -1.12% +64.19%
Apr. 08 Sensorion: completion of a private placement CF
Apr. 05 Sensorion SA announced that it expects to receive ?15 million in funding CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 27.19 115.1 153.4 29.56 80.38 194.5 - -
Enterprise Value (EV) 1 17.79 115.1 107.4 7.116 80.38 143.5 189.5 194.5
P/E ratio -1.3 x -10 x -10.1 x -1.28 x - -5.65 x -4.55 x -23.5 x
Yield - - - - - - - -
Capitalization / Revenue 10.8 x 47.5 x 35.3 x 5.9 x 14.1 x 13.4 x 13.3 x 9.15 x
EV / Revenue 7.05 x 47.5 x 24.7 x 1.42 x 14.1 x 9.85 x 13 x 9.15 x
EV / EBITDA - -13.4 x -7.31 x -0.32 x - -5.15 x -4.78 x -57.2 x
EV / FCF -1.25 x - -9.56 x -0.31 x - -4.95 x -4.12 x -
FCF Yield -79.8% - -10.5% -321% - -20.2% -24.3% -
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 32,178 76,720 79,672 79,881 186,936 275,502 - -
Reference price 2 0.8450 1.500 1.926 0.3700 0.4300 0.7060 0.7060 0.7060
Announcement Date 4/2/20 3/18/21 4/28/22 3/16/23 3/14/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 2.523 2.421 4.349 5.006 5.698 14.57 14.63 21.27
EBITDA 1 - -8.577 -14.69 -22.37 - -27.85 -39.65 -3.4
EBIT 1 -10.81 -8.889 -15.02 -23.14 -22.31 -28.3 -40.05 -3.8
Operating Margin -428.67% -367.13% -345.5% -462.22% -391.54% -194.28% -273.69% -17.87%
Earnings before Tax (EBT) 1 -12.1 -8.978 -15.14 -23.21 - -28.2 -39.95 -3.7
Net income 1 -12.1 -8.978 -15.14 -23.21 -22.06 -28.25 -39.95 -5.65
Net margin -479.49% -370.8% -348.08% -463.67% -387.21% -193.94% -273.01% -26.57%
EPS 2 -0.6500 -0.1500 -0.1900 -0.2900 - -0.1250 -0.1550 -0.0300
Free Cash Flow 1 -14.19 - -11.24 -22.81 - -29 -46 -
FCF margin -562.53% - -258.54% -455.69% - -199.08% -314.35% -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 4/2/20 3/18/21 4/28/22 3/16/23 3/14/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2023 S1 2024 S1 2024 S2 2025 S1 2025 S2
Net sales 1 0.9022 1.519 1.604 2.745 1.901 2.647 2.74 2.96 3 3
EBITDA 1 - - - - - - -12.5 -14.6 - -
EBIT - -4.214 - -8.876 -12.22 - - - - -
Operating Margin - -277.43% - -323.36% -642.42% - - - - -
Earnings before Tax (EBT) 1 - -4.259 - -8.894 -12.26 -12.29 -12.3 -14.6 - -
Net income 1 -4.719 -4.259 -6.243 -8.894 -12.26 -12.29 -12.36 -14.6 - -
Net margin -523.05% -280.38% -389.27% -324.01% -645.01% -464.14% -451.09% -493.24% - -
EPS 2 - -0.0600 - -0.1100 -0.1500 - -0.0700 -0.0800 - -
Dividend per Share - - - - - - - - - -
Announcement Date 10/21/20 3/18/21 9/27/21 4/28/22 9/22/22 9/20/23 - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 9.4 - 46 22.4 - 51 5 -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 -14.2 - -11.2 -22.8 - -29 -46 -
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 0.02 0.08 0.47 1.42 - 0.7 0.7 0.7
Capex / Sales 0.9% 3.13% 10.81% 28.47% - 4.81% 4.78% 3.29%
Announcement Date 4/2/20 3/18/21 4/28/22 3/16/23 3/14/24 - - -
1EUR in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Sensorion

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
0.706 EUR
Average target price
2.375 EUR
Spread / Average Target
+236.40%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
SENSORION Stock Sensorion
+64.19% 208M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. ALSEN Stock
  4. Financials Sensorion